US Patent Issued to EMORY UNIVERSITY on April 7 for "Phosphoramidates for the treatment of hepatitis B virus" (Georgia Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,595,280, issued on April 7, was assigned to EMORY UNIVERSITY (Atlanta).

"Phosphoramidates for the treatment of hepatitis B virus" was invented by Abel de la Rosa (Alpharetta, Ga.) and Gregory R. Bluemling (Decatur, Ga.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed are compounds to the treatment of infectious diseases and methods of treating such diseases. The compounds are derivatives of clevudine."

The patent was filed on April 11, 2024, under Application No. 18/632,908.

*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&p=1&u=%2Fnetahtml%2FPTO%2Fse...